OptimizeRx expects 2023 revenue to exceed its forecast, shares jump

OptimizeRx

09/01/2024 15:42

** Shares of digital health co OptimizeRx  OPRX.O  rise
15.6% to an over 7-month high of $15.44 
    ** Co expects its 2023 revenue to exceed its forecast of $68
mln to 70 mln given, driven by its AI-based platform that helped
pharma, medical tech and other companies better target
physicians and patients
    ** Analysts on average estimate co's 2023 revenue to be
$68.8 mln - LSEG data
    ** OPRX stock fell 14.9% in 2023

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))